Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM101 in chronic adult idiopathic thrombocytopenic purpura
ISRCTN47912914Phase 2Completed
- Sponsor
- Baxter International Inc.
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of valziflocept in immune thrombocytopenia (ITP), sponsored by Baxter International Inc.. Started Apr 2010; status: completed.
02
Drugs
valziflocept
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ISRCTN47912914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN47912914.